glp-1 cancer reduction Could Drugs Reduce Obesity-Related Cancers in the Future? GLP-1 meds slow cancer progression

Our team will tailor the plan based on your individual needs and how your body responds to treatment

Patients with NASH are at risk of developing cirrhosis/liver cancer and new therapies must be developed to combat the illness

Mechanistically, it does something newer GLP-1s do not

Speak with a provider first if you have: A history of cancer or active malignancy Uncontrolled diabetes or blood sugar concerns Severe swelling or fluid retention Sleep apnea or breathing concerns Significant heart, kidney, or liver disease Pregnancy, breastfeeding, or pregnancy plans Severe headaches or vision changes Current hormone-related treatment A history of allergic reactions to injections Unverified peptide products purchased online A provider can help decide whether Ipamorelin is appropriate, whether lab review is needed, and whether another peptide therapy option may be safer